GENEVA, Sept. 18 -- THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY filed a patent application (US2026/017474) for “CHEMOKINE RECEPTOR BLOCKADE FOR TREATMENT OF COGNITIVE DYSFUNCTION FOLLOWING CANCER IMMUNOTHERAPY”. With publication no. WO/2026/187776, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 40/31
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....